Stocks › MPLT
MapLight Therapeutics MPLT
US equityMarket cap rank #3724
$6.93 +$0.71 (+11.41%)
Market closed · Nov 6, 8:10 pm ET · Last extended-hours $7.60 +9.67%
Open$6.24
Prev close$6.22
Day range$6.06 – $6.93
Volume502.0K
Market cap$385.14M
P/E (TTM)–
Dividend yield–
MPLT Stock News
Headlines matching MapLight Therapeutics or the MPLT ticker, most recent first.
- Needham Maintains MapLight Therapeutics(MPLT.US) With Buy Rating, Cuts Target Price to $43 Negative
- Morgan Stanley Maintains MapLight Therapeutics(MPLT.US) With Hold Rating, Maintains Target Price $21
- Morgan Stanley Keeps Their Hold Rating on MapLight Therapeutics, Inc. (MPLT)
- LifeSci Capital Maintains MapLight Therapeutics(MPLT.US) With Buy Rating, Maintains Target Price $37
- Analysts Offer Insights on NA Companies: CAMP4 Therapeutics Corporation (CAMP), MapLight Therapeutics, Inc. (MPLT) and Andersen Group, Inc. Class A (ANDG)
- Analysts' Top NA Picks: Solv Energy (MWH), MapLight Therapeutics, Inc. (MPLT)
- BMO Capital Initiates MapLight Therapeutics(MPLT.US) With Buy Rating, Announces Target Price $20
- UBS Maintains MapLight Therapeutics(MPLT.US) With Hold Rating, Maintains Target Price $13
- UBS Downgrades MapLight Therapeutics(MPLT.US) to Hold Rating, Cuts Target Price to $13 Negative
- MapLight Therapeutics, Inc. (MPLT) Gets a Buy From Jefferies
- Morgan Stanley Downgrades MapLight Therapeutics(MPLT.US) to Hold Rating, Cuts Target Price to $21 Negative
- A Quick Look at Today's Ratings for MapLight Therapeutics(MPLT.US), With a Forecast Between $21 to $45
- Craig-Hallum Maintains MapLight Therapeutics(MPLT.US) With Buy Rating, Cuts Target Price to $25 Negative
- Analysts Are Bullish on Top NA Stocks: Safe Pro Group, Inc. (SPAI), MapLight Therapeutics, Inc. (MPLT) Positive
- Analysts Are Bullish on Top NA Stocks: Syensqo SA/NV (SHBBF), MapLight Therapeutics, Inc. (MPLT) Positive
No comments yet — be the first to weigh in on MPLT.
Sign in to join the discussion.